New aspects in the treatment of multiple sclerosis with Interferon beta-1b OriginalPaper Pages: ivI - ivI
New aspects in the treatment of multiple sclerosis with interferon beta-1b Ludwig Kappos OriginalPaper Pages: iv1 - iv1
Recent neuropathological findings in MS—implications for diagnosis and therapy Hans Lassmann OriginalPaper Pages: iv2 - iv5
Assessing treatment effects on axonal loss—evidence from MRI monitored clinical trials Frederik Barkhof OriginalPaper Pages: iv6 - iv12
Is multiple sclerosis a disease that requires frequent beta interferon dosing? Luca Durelli OriginalPaper Pages: iv13 - iv24
Neurorehabilitation in multiple sclerosis—what is the evidence-base? Jürg Kesselring OriginalPaper Pages: iv25 - iv29
The pros and cons of early treatment of relapsing forms of multiple sclerosis Xavier Montalban OriginalPaper Pages: iv30 - iv34
